Most people qualify based on BMI thresholds and the presence of weight-related health conditions, plus a clinicians safety screening
Clinical trials for orforglipron have shown encouraging results: Orforglipron: Approximately a 1.6% reduction in HbA1c and an 8% body weight reduction (~16 pounds) after 40 weeks, with no strict fasting or water-intake rules,
Medicare aims to address the rising prevalence of obesity and its chronic complications through this bridge
When you are obese, you should always change your lifestyle along with taking medicine
The Surprising Connection Youve been diligent, tracking your cycle and paying attention to your body's signals
Inform your doctor if you have a history of pancreatitis, thyroid cancer, or diabetic retinopathy